372 related articles for article (PubMed ID: 31614216)
1. Searching for the Culprit Drugs for Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis from a Nationwide Claim Database in Korea.
Yang MS; Lee JY; Kim J; Kim GW; Kim BK; Kim JY; Park HW; Cho SH; Min KU; Kang HR
J Allergy Clin Immunol Pract; 2020 Feb; 8(2):690-695.e2. PubMed ID: 31614216
[TBL] [Abstract][Full Text] [Related]
2. Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis associated with anticonvulsants in a Japanese population: Matched case-control and cohort studies.
Fukasawa T; Takahashi H; Takahashi K; Tanemura N; Amagai M; Urushihara H
Allergol Int; 2021 Jul; 70(3):335-342. PubMed ID: 33618992
[TBL] [Abstract][Full Text] [Related]
3. The risk of Stevens-Johnson syndrome and toxic epidermal necrolysis in new users of antiepileptic drugs.
Frey N; Bodmer M; Bircher A; Rüegg S; Jick SS; Meier CR; Spoendlin J
Epilepsia; 2017 Dec; 58(12):2178-2185. PubMed ID: 29027197
[TBL] [Abstract][Full Text] [Related]
4. Is acetaminophen associated with a risk of Stevens-Johnson syndrome and toxic epidermal necrolysis? Analysis of the French Pharmacovigilance Database.
Lebrun-Vignes B; Guy C; Jean-Pastor MJ; Gras-Champel V; Zenut M;
Br J Clin Pharmacol; 2018 Feb; 84(2):331-338. PubMed ID: 28963996
[TBL] [Abstract][Full Text] [Related]
5. Review of culprit drugs associated with patients admitted to the burn unit with the diagnosis of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Syndrome.
de Bustros P; Baldea A; Sanford A; Joyce C; Adams W; Bouchard C
Burns; 2022 Nov; 48(7):1561-1573. PubMed ID: 34924230
[TBL] [Abstract][Full Text] [Related]
6. Culprit Medications and Risk Factors Associated with Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Population-Based Nested Case-Control Study.
Gronich N; Maman D; Stein N; Saliba W
Am J Clin Dermatol; 2022 Mar; 23(2):257-266. PubMed ID: 35119606
[TBL] [Abstract][Full Text] [Related]
7. Incidence of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Nationwide Population-Based Study Using National Health Insurance Database in Korea.
Yang MS; Lee JY; Kim J; Kim GW; Kim BK; Kim JY; Park HW; Cho SH; Min KU; Kang HR
PLoS One; 2016; 11(11):e0165933. PubMed ID: 27835661
[TBL] [Abstract][Full Text] [Related]
8. ALDEN, an algorithm for assessment of drug causality in Stevens-Johnson Syndrome and toxic epidermal necrolysis: comparison with case-control analysis.
Sassolas B; Haddad C; Mockenhaupt M; Dunant A; Liss Y; Bork K; Haustein UF; Vieluf D; Roujeau JC; Le Louet H
Clin Pharmacol Ther; 2010 Jul; 88(1):60-8. PubMed ID: 20375998
[TBL] [Abstract][Full Text] [Related]
9. Agreement Among Different Scales for Causality Assessment in Drug-Induced Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
Sivagourounadin K; Rajendran P; Selvarajan S; Ganesapandian M
Curr Drug Saf; 2022; 17(1):40-46. PubMed ID: 34126908
[TBL] [Abstract][Full Text] [Related]
10. Toxic epidermal necrolysis and Stevens-Johnson syndrome/toxic epidermal necrolysis overlap in pediatric patients with a focus on newer antiepileptic drugs: A 25-year retrospective study at a single tertiary care center.
Gleghorn KL; Voigt C; Kelly B
Pediatr Dermatol; 2021 Jul; 38(4):812-818. PubMed ID: 34060145
[TBL] [Abstract][Full Text] [Related]
11. A Nationwide Study of Severe Cutaneous Adverse Reactions Based on the Multicenter Registry in Korea.
Kang DY; Yun J; Lee SY; Koh YI; Sim DW; Kim S; Nam YH; Park JW; Kim SH; Ye YM; Park HK; Kim MH; Jee YK; Jung JW; Yang MS; Kim SH; Lee JK; Kim CW; Hur GY; Kim MY; Park SJ; Kwon YE; Choi JH; Kim JH; Kim SH; La HO; Kang MG; Park CS; Lee SM; Jeong YY; Kim HK; Jin HJ; Jeong JW; Lee J; Lee YW; Lee SE; Kim MS; Kang HR;
J Allergy Clin Immunol Pract; 2021 Feb; 9(2):929-936.e7. PubMed ID: 32961314
[TBL] [Abstract][Full Text] [Related]
12. Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Association with Commonly Prescribed Drugs in Outpatient Care Other than Anti-Epileptic Drugs and Antibiotics: A Population-Based Case-Control Study.
Frey N; Bodmer M; Bircher A; Jick SS; Meier CR; Spoendlin J
Drug Saf; 2019 Jan; 42(1):55-66. PubMed ID: 30112729
[TBL] [Abstract][Full Text] [Related]
13. Adverse drug reaction causality assessment tools for drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: room for improvement.
Goldman JL; Chung WH; Lee BR; Chen CB; Lu CW; Hoetzenecker W; Micheletti R; Yasuda SU; Margolis DJ; Shear NH; Struewing JP; Pirmohamed M
Eur J Clin Pharmacol; 2019 Aug; 75(8):1135-1141. PubMed ID: 30918988
[TBL] [Abstract][Full Text] [Related]
14. Drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in vietnamese spontaneous adverse drug reaction database: A subgroup approach to disproportionality analysis.
Nguyen KD; Tran TN; Nguyen MT; Nguyen HA; Nguyen HA; Vu DH; Nguyen VD; Bagheri H
J Clin Pharm Ther; 2019 Feb; 44(1):69-77. PubMed ID: 30129156
[TBL] [Abstract][Full Text] [Related]
15. Incidence of Stevens-Johnson syndrome/toxic epidermal necrolysis among new users of different individual drugs in a European population: a case-population study.
Rodríguez-Martín S; Martín-Merino E; Lerma V; Rodríguez-Miguel A; González O; González-Herrada C; Ramírez E; Bellón T; de Abajo FJ
Eur J Clin Pharmacol; 2019 Feb; 75(2):237-246. PubMed ID: 30298362
[TBL] [Abstract][Full Text] [Related]
16. Drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in children: 20 years study in a tertiary care hospital.
Techasatian L; Panombualert S; Uppala R; Jetsrisuparb C
World J Pediatr; 2017 Jun; 13(3):255-260. PubMed ID: 27650525
[TBL] [Abstract][Full Text] [Related]
17. Spontaneous adverse event reports of Stevens-Johnson syndrome/toxic epidermal necrolysis: detecting associations with medications.
Papay J; Yuen N; Powell G; Mockenhaupt M; Bogenrieder T
Pharmacoepidemiol Drug Saf; 2012 Mar; 21(3):289-96. PubMed ID: 22139991
[TBL] [Abstract][Full Text] [Related]
18. Incidence, causative factors and mortality rates of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) in northern Italy: data from the REACT registry.
Diphoorn J; Cazzaniga S; Gamba C; Schroeder J; Citterio A; Rivolta AL; Vighi GD; Naldi L;
Pharmacoepidemiol Drug Saf; 2016 Feb; 25(2):196-203. PubMed ID: 26687641
[TBL] [Abstract][Full Text] [Related]
19. Assessment of Need for Improved Identification of a Culprit Drug in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis.
Li DJ; Velasquez GA; Romar GA; Schunkert EM; Foreman RK; Divito SJ
JAMA Dermatol; 2023 Aug; 159(8):830-836. PubMed ID: 37342052
[TBL] [Abstract][Full Text] [Related]
20. Risk of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Associated With Antibiotic Use: A Case-Crossover Study.
Fukasawa T; Urushihara H; Takahashi H; Okura T; Kawakami K
J Allergy Clin Immunol Pract; 2023 Nov; 11(11):3463-3472. PubMed ID: 37459954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
